Masahiro Mori (M Mori)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Topics

Ankylosing Spondylitis

Duchenne Muscular Dystrophy

Spectrum Disorder

Top Venues

Journal of neurology, neurosurgery, and psychiatry

Multiple sclerosis (Houndmills, Basingstoke, England)

Multiple sclerosis journal - experimental, translational and clinical

This page only lists publications with an associated author ORCID identifier.

Publications

Akiyuki Uzawa, Masahiro Mori, Hiroki Masuda, Tomohiko Uchida, Mayumi Muto, Ryohei Ohtani, Shinji Aoyama, Satoshi Kuwabara
Long-term disability progression in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a retrospective analysis of 101 patients. Journal of neurology, neurosurgery, and psychiatry 95 (7) (2024)
Akiyuki Uzawa, Masahiro Mori, Hiroki Masuda, Mayumi Muto, Ryohei Ohtani, Shinji Aoyama, Kazuyuki Matsushita, Satoshi Kuwabara
Contributions of CSF interleukin-6 elevation to the pathogenesis of myelin oligodendrocyte glycoprotein antibody-associated disease. Multiple sclerosis (Houndmills, Basingstoke, England) (2024)
Akiyuki Uzawa, Masahiro Mori, Hiroki Masuda, Tomohiko Uchida, Mayumi Muto, Ryohei Ohtani, Shinji Aoyama, Satoshi Kuwabara
Long-term disability progression in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a retrospective analysis of 101 patients. Journal of neurology, neurosurgery, and psychiatry 95 (7) (2024)
Akiyuki Uzawa, Frederike Cosima Oertel, Masahiro Mori, Friedemann Paul, Satoshi Kuwabara
NMOSD and MOGAD: an evolving disease spectrum. Nature reviews. Neurology (2024)
Akiyuki Uzawa, Masahiro Mori, Hiroki Masuda, Tomohiko Uchida, Mayumi Muto, Ryohei Ohtani, Shinji Aoyama, Satoshi Kuwabara
Long-term disability progression in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a retrospective analysis of 101 patients. Journal of neurology, neurosurgery, and psychiatry 95 (7) (2024)
Akiyuki Uzawa, Masahiro Mori, Hiroki Masuda, Tomohiko Uchida, Mayumi Muto, Ryohei Ohtani, Shinji Aoyama, Satoshi Kuwabara
Long-term disability progression in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a retrospective analysis of 101 patients. Journal of neurology, neurosurgery, and psychiatry (2024)
Akiyuki Uzawa, Masahiro Mori, Hiroki Masuda, Mayumi Muto, Ryohei Ohtani, Shinji Aoyama, Kazuyuki Matsushita, Satoshi Kuwabara
Contributions of CSF interleukin-6 elevation to the pathogenesis of myelin oligodendrocyte glycoprotein antibody-associated disease. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (8) (2024)
Susanna Asseyer, Hiroki Masuda, Masahiro Mori, Judith Bellmann-Strobl, Klemens Ruprecht, Nadja Siebert, Graham Cooper, Claudia Chien, Ankelien Duchow, Jana Schließeit, Jia Liu, Kazuo Sugimoto, Akiyuki Uzawa, Ryohei Ohtani, Friedemann Paul, Alexander Ulrich Brandt, Satoshi Kuwabara, Hanna G Zimmermann
AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders. Multiple sclerosis journal - experimental, translational and clinical 7 (2) (2021)
Akiyuki Uzawa, Masahiro Mori, Satoshi Kuwabara
Different patterns of brainstem and cerebellar MRI abnormalities in demyelinating disorders with MOG and aquaporin-4 antibodies. Journal of neurology, neurosurgery, and psychiatry (2021)
Kazuo Sugimoto, Masahiro Mori, Jia Liu, Kazumoto Shibuya, Sagiri Isose, Mizuho Koide, Takaki Hiwasa, Satoshi Kuwabara
Novel serum autoantibodies against ß-actin (ACTB) in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration 22 (5-6) (2021)
Hiroki Masuda, Masahiro Mori, Satoshi Kuwabara
Remyelination and neuroprotective effects of alemtuzumab therapy in patients with multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry 92 (12) (2021)
Hiroki Masuda, Masahiro Mori, Shigeki Hirano, Akiyuki Uzawa, Tomohiko Uchida, Mayumi Muto, Ryohei Ohtani, Reiji Aoki, Satoshi Kuwabara
Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder. Journal of neurology, neurosurgery, and psychiatry (2021)
Hiroki Masuda, Masahiro Mori, Akiyuki Uzawa, Tomohiko Uchida, Ryohei Ohtani, Satoshi Kuwabara
Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis. PloS one 15 (4) (2020)
Jia Liu, Masahiro Mori, Hanna Zimmermann, Alexander Brandt, Joachim Havla, Satoru Tanaka, Kazuo Sugimoto, Satoru Oji, Akiyuki Uzawa, Susanna Asseyer, Graham Cooper, Sven Jarius, Judith Bellmann-Strobl, Klemens Ruprecht, Nadja Siebert, Hiroki Masuda, Tomohiko Uchida, Ryohei Ohtani, Kyoichi Nomura, Edgar Meinl, Tania Kuempfel, Friedemann Paul, Satoshi Kuwabara
Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and Germany. Journal of neurology, neurosurgery, and psychiatry (2020)
Hiroki Masuda, Masahiro Mori, S Hirano, Akiyuki Uzawa, T Uchida, Ryohei Ohtani, R Aoki, S Kuwabara
Comparison of brain atrophy in patients with multiple sclerosis treated with first- versus second-generation disease modifying therapy without clinical relapse. European journal of neurology 27 (10) (2020)
Shinobu Shimizu, Masahiro Iijima, Yuki Fukami, Natsuko Tamura, Masahiro Nakatochi, Masahiko Ando, Ryoji Nishi, Haruki Koike, Ken-Ichi Kaida, Michiaki Koga, Takashi Kanda, Hidenori Ogata, Jun-Ichi Kira, Masahiro Mori, Satoshi Kuwabara, Masahisa Katsuno
Efficacy and Safety of Rituximab in Refractory CIDP With or Without IgG4 Autoantibodies (RECIPE): Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial. JMIR research protocols 9 (4) (2020)
Jia Liu, Masahiro Mori, Kazuo Sugimoto, Akiyuki Uzawa, Hiroki Masuda, Tomohiko Uchida, Ryohei Ohtani, Satoshi Kuwabara
Peripheral blood helper T cell profiles and their clinical relevance in MOG-IgG-associated and AQP4-IgG-associated disorders and MS. Journal of neurology, neurosurgery, and psychiatry 91 (2) (2019)
Masahiro Mori, Takashi Ohashi, Yasuhiro Onizuka, Katsutoshi Hiramatsu, Masakazu Hase, Jang Yun, André Matta, Shinichi Torii
Efficacy and safety of dimethyl fumarate in treatment-naïve Japanese patients with multiple sclerosis: Interim analysis of the randomized placebo-controlled study. Multiple sclerosis journal - experimental, translational and clinical 5 (2) (2019)
Shinji Aoyama, Masahiro Mori, Akiyuki Uzawa, Tomohiko Uchida, Hiroki Masuda, Ryohei Ohtani, Satoshi Kuwabara
Serum anti-John Cunningham virus antibody seroprevalence and index among Japanese patients with neuromyelitis optica spectrum disorders. Multiple sclerosis (Houndmills, Basingstoke, England) 26 (1) (2018)
Hiroki Masuda, Shigeki Hirano, Nobuyoshi Takahashi, Etsuko Hatsugano, Akiyuki Uzawa, Tomohiko Uchida, Ryohei Ohtani, Satoshi Kuwabara, Masahiro Mori
Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder. PloS one 12 (8) (2017)